Home > Insider Trading > Filing (0000874015-14-000068)

Filing Details

Accession Number:: 0000874015-14-000068
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-07-02 16:08:47
Reporting Period:: 2014-07-01

Filing Date:: 2014-07-02
Accepted Time:: 2014-07-02 16:08:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874015	Isis Pharmaceuticals Inc	ISIS	Pharmaceutical Preparations (2834)	330336973

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
897667	T Stanley Crooke	C/O Isis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010	Chairman And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-07-01	15,500	$14.47	22,441	No	4	M	Direct
Common Stock	Disposition	2014-07-01	15,500	$35.58	6,941	No	4	S	Direct
Common Stock	Acquisiton	2014-07-01	200	$14.47	827	No	4	M	Indirect	By Wife
Common Stock	Disposition	2014-07-01	200	$35.55	627	No	4	S	Indirect	By Wife
Common Stock	Acquisiton	2014-07-01	1,800	$11.27	2,427	No	4	M	Indirect	By Wife
Common Stock	Disposition	2014-07-01	1,800	$35.55	627	No	4	S	Indirect	By Wife

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Indirect	By Wife
No	4	S	Indirect	By Wife
No	4	M	Indirect	By Wife
No	4	S	Indirect	By Wife

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2014-07-01	15,500	$0.00	15,500	$14.47
Common Stock	Employee Stock Option (right to buy)	Disposition	2014-07-01	200	$0.00	200	$14.47
Common Stock	Employee Stock Option (right to buy)	Disposition	2014-07-01	1,800	$0.00	1,800	$11.27

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
66,500	2013-01-02	2016-01-02	No	4	M	Direct
0	2013-01-02	2016-01-02	No	4	M	Indirect
4,800	2014-01-04	2017-01-03	No	4	M	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	725,391	Indirect	By Trust

Footnotes

Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 8/6/13.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.51 to $35.65, inclusive. The reporting person undertakes to provide to Isis Pharmaceuticals, Inc., any security holder of Isis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person's wife on 8/6/13.
Grant of 1/2/2009 to reporting person of stock options under the Isis Pharmacueticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/2/2010. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 37,500 shares per year. Following this transaction, the option was exercisable as to 66,500 on 7/1/14.
Grant of 1/4/10 to reporting person's wife of stock options under the Isis Pharmacueticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/4/11. Thereafter, the remaining shares subject to the option vest and become exercisalbe in 36 equal monthly installments, at the rate of 1,650 shares per year. Following this transaction, the option was exercisable as to 4,800 on 7/1/2014.